Therefore, our results demonstrated the anti-inflammatory effect of C3aRA in T2DM rats, and that this effect may be because of its inhibition of IKBα phosphorylation and NF-κB activation in GECs of the kidney. The gene discussed is NFKB1; the disease is type 2 diabetes mellitus.